Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison of Clinical Characteristics between Adenoviral and Group A Streptococcal Pharyngitis in Children

소아의 아데노바이러스와 A군 연쇄구균 인두염의 임상적 특징의 비교

  • Kim, So Hyong (Department of Pediatrics, Dongguk University Ilsan Hospital) ;
  • Jeong, Hye Ryeong (Department of Pediatrics, Dongguk University Ilsan Hospital) ;
  • Kim, In Uk (Department of Pediatrics, Dongguk University Ilsan Hospital) ;
  • Yang, Mu Yeol (Department of Pediatrics, Dongguk University Ilsan Hospital) ;
  • Cho, Sung Min (Department of Pediatrics, Dongguk University Ilsan Hospital) ;
  • Kang, Eun Kyeong (Department of Pediatrics, Dongguk University Ilsan Hospital)
  • 김소형 (동국대학교 일산병원 소아청소년과) ;
  • 정혜령 (동국대학교 일산병원 소아청소년과) ;
  • 김인욱 (동국대학교 일산병원 소아청소년과) ;
  • 양무열 (동국대학교 일산병원 소아청소년과) ;
  • 조성민 (동국대학교 일산병원 소아청소년과) ;
  • 강은경 (동국대학교 일산병원 소아청소년과)
  • Received : 2014.02.20
  • Accepted : 2014.05.01
  • Published : 2014.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To compare the clinical characteristics and laboratory finding between adenoviral and group A streptococcal (GAS) pharyngitis. Methods: A retrospective review of medical records was performed in the patients with adenovirus infection among those who were admitted for febrile respiratory disease from January 2011 to July 2013 and GAS pharyngitis among those who visited for symptoms of scarlet fever from August 2006 to July 2013. Results: 179 patients (AV1 group) were diagnosed with adenoviral pharyngitis and 37 (AV2 group) of these patients had adenovirus single infection. 26 patients (GAS group) were diagnosed with scarlet fever. Adenoviral infection (AV2 group) developed in younger patients compared to GAS group ($2.8{\pm}2.1$ years vs. $5.4{\pm}1.8$ years, P =0.000). Total durations of fever and admission were longer in AV2 ($6.3{\pm}2.6$ days vs. $3.3{\pm}1.9$ days, P =0.000; $4.1{\pm}1.2$ days vs. $1.9{\pm}1.8$ days, P =0.000, respectively). WBC counts were higher in AV2 ($11,449{\pm}5,680$ cells/$mm^2$ vs. $6,722{\pm}6,941$ cells/$mm^2$, P =0.000). CRP was not significantly different between AV2 and GAS group ($3.8{\pm}3.2$ mg/dL vs. $5.2{\pm}5.1$ mg/dL, P =0.368). No difference was found between two groups in the percentage of antibiotics use (91.9% vs. 100%, P =0.261). Conclusion: Clinical characteristics and measures of inflammation in the laboratory findings were similar between adenoviral and GAS pharyngitis group. It is necessary to conduct the test for respiratory virus and bacteria in early stage to differentiate in the pharyngitis patients with leukocytosis and elevation of CRP level.

목적: 본 연구는 아데노바이러스와 A군 연쇄구균에 의한 인두염에서 임상적 특징과 검사 소견의 차이를 비교하였다. 방법: 2011년 1월부터 2013년 7월까지 열성 호흡기 질환으로 입원한 환자 중 아데노바이러스 감염 환자와 2006년 8월부터 2013년 7월까지 성홍열의 증상으로 내원하여 A군 연쇄구균 인두염으로 진단된 환자를 대상으로 의무 기록을 후향적으로 분석하였다. 결과: 179명(AV1군)이 아데노바이러스 인두염으로 진단되었고, 이 중 37명(AV2군)이 아데노바이러스 단독 감염이었다. 26명(GAS군)의 환자가 성홍열로 진단되었다. 아데노바이러스 감염(AV2군)은 GAS군에 비하여 더 어린 연령에서 발병하였다($2.8{\pm}2.1$세 vs. $5.4{\pm}1.8$세, P =0.000). 총 발열 기간과 입원 기간은 AV2군에서 더 길었다(각각 $6.3{\pm}2.6$일 vs. $3.3{\pm}1.9$일, P =0.000; $4.1{\pm}1.2$일 vs. $1.9{\pm}1.8$일, P =0.000). 백혈구 수는 AV2군에서 높았다($11,449{\pm}5,680/mm^3$ vs. $6,722{\pm}6,941/mm^3$, P =0.000). CRP는 AV2군과 GAS군에서 유의한 차이가 없었다($3.8{\pm}3.2$ mg/dL vs. $5.2{\pm}5.1$ mg/dL, P =0.368). 항생제 사용 비율은 두 군에서 차이가 없었다(91.9% vs. 100%, P =0.261). 결론: 임상적 특징과 검사 소견에서 염증의 척도는 아데노바이러스와 A군 연쇄구균에 의한 인두염에서 유사하였다. 백혈구 및 CRP의 상승이 동반된 인두염 환자에서 감별을 위해 조기에 호흡기 바이러스와 세균 검사를 시행하는 것이 필요하다.

Keywords

References

  1. Kwon HJ, Rhie YJ, Seo WH, Jang GY, Choi BM, Lee JH, et al. Clinical manifestations of respiratory adenoviral infection among hospitalized children in Korea. Pediatrics International 2013;55:450-4. https://doi.org/10.1111/ped.12108
  2. Kawasaki Y, Hosoya M, Katayose M, Suzuki H. Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection. Pediatr Infect Dis J 2002;21:370-4. https://doi.org/10.1097/00006454-200205000-00004
  3. Chen HL, Chiou SS, Hsiao HP, Ke GM, Lin YC, Lin KH, et al. Respiratory adenoviral infections in children:a study of hospitalized cases in southern Taiwan in 2001-2002, J Trop Pediatr 2004;50:279-84. https://doi.org/10.1093/tropej/50.5.279
  4. Cherry JD. Adenoviruses. In : Feigin RD, Cherry JD, editors. Textbook of Pediatric Infectious Disease. 2nd ed. Philadelphia: WB Saunders Co, 1998:1666-84.
  5. Ruuskanen O, Meurman O, Sarkkinen H. Adenoviral diseases in children: a study of 105 cases. Pediatrics 1985;76:79-83.
  6. Putto A, Meurman O, Ruuskanen O. C-reactive protein in the differentiation of adenoviral, Epstein-Barr viral and streptococcal tonsillitis in children. Eur J Pediatr 1986;145:204-6. https://doi.org/10.1007/BF00446066
  7. Mistchenko AS, Diez RA, Mariani AL, Robaldo J, Maffey AF, Bay-ley-Bustamante G, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994;124:714-20. https://doi.org/10.1016/S0022-3476(05)81360-5
  8. Peltola V, Mertsola J, Ruuskanen O. Comparison of total white blood cell count and serum c-reactive protein levels in confirmed bacterial and viral infections. J Pediatr 2006;149:721-4. https://doi.org/10.1016/j.jpeds.2006.08.051
  9. American College of Emergency Physicians Clinical Policies Committee; Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med 2003;42:530-45. https://doi.org/10.1067/S0196-0644(03)00628-0
  10. Toikka P, Irjala K, Juvén T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19:598-602. https://doi.org/10.1097/00006454-200007000-00003
  11. Jartti T, Lehtinen P, Vuorinen T, Österback R, van den Hoogen B, Osterhaus AD, et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 2004;10:1095-101. https://doi.org/10.3201/eid1006.030629
  12. Ruuskanen O, Sarkkinen H, Meurman O, Hurme P, Rossi T, Halonen P, et al. Rapid diagnosis of adenoviral tonsillitis: a prospective clinical study. J Pediatr 1984;104:725-8. https://doi.org/10.1016/S0022-3476(84)80952-X
  13. Dominguez O, Rojo P, de Las Heras S, Folgueira D, Contreras JR. Clinical presentation and characteristics of pharyngeal adenovirus infections. Pediatr Infect Dis J 2005;24:733-4. https://doi.org/10.1097/01.inf.0000172942.96436.2d
  14. Peled N, Nakar C, Huberman H, Scherf E, Samra Z, Finkelstein Y, et al. Adenovirus infection in hospitalized immunocompetent children. Clin Pediatr (Phila). 2004;43:223-9. https://doi.org/10.1177/000992280404300303
  15. Ruuskanen O, Putto A, Sarkkinen H, Meurman O, Irjala K. C-reactive protein in respiratory virus infections. J Pediatr 1985;107:97-100. https://doi.org/10.1016/S0022-3476(85)80624-7
  16. Appenzeller C, Ammann RA, Duppenthaler A, Gorgievski-Hrisoho M, Aebi C. Serum C-reactive protein in children with adenovirus infection. Swiss Med Wkly 2002;132:345-50.
  17. Hsieh TH, Chen PY, Huang FL, Wang JD, Wang LC, Lin HK, et al. Are empiric antibiotics for acute exudative tonsillitis needed in children? J Microbiol Immunol Infect 2011;44:328-32. https://doi.org/10.1016/j.jmii.2010.08.009
  18. Chi H, Chiu NC, Li WC, Huang FY. Etiology of acute pharyngitis in children: is antibiotic therapy needed? J Microbiol Immunol Infect 2003;36:26-30.
  19. Sun J, Wu KG, Hwang B. Evaluation of the etiologic agents for acute suppurative tonsillitis in children. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65:212-7.
  20. Douglas RM, Miles H, Hansman D, Fadejevs A, Moore B, Bollen MD. Acute tonsillitis in children: microbial pathogens in relation to age. Pathology 1984;16:79-82. https://doi.org/10.3109/00313028409067915
  21. Putto A. Febrile exudative tonsillitis: viral or streptococcal? Pediatrics 1987;80:6-12.
  22. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001;108:1275-9. https://doi.org/10.1542/peds.108.6.1275
  23. Peltola H, Jaakkola M. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr 1988;113:641-6. https://doi.org/10.1016/S0022-3476(88)80372-X
  24. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154:453-6. https://doi.org/10.1001/archpedi.154.5.453
  25. Bierbaum S, Forster J, Berner R, Rucker G, Rohde G, Neumann-Haefelin D, et al. Detection of respiratory viruses using a multiplex real-time PCR assay in Germany, 2009/10. Arch Virol. 2013;15:[Epub ahead of print]
  26. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician 1997;55:1647-54.